The U.S. Food and Drug Administration today recommended more conservative dosing guidelines for Erythropoiesis-Stimulating Agents (ESAs) when used to treat anemia in patients with chronic kidney disease (CKD) because of the increased risks of cardiovascular events...
In a new article in Toxicology in Vitro , PCRM toxicologists lay out how legislation can encourage the development of better methods that would help replace the use of animals.
TigerTox: #Pharma/Biotech firms want drug approval hastened – The Boston Globe http://bo.st/BIO2011DrugApprovalIdeas #in #toxicology
The U.S. Food and Drug Administration released a report today updating the clinical and scientific information for silicone gel-filled breast implants, including preliminary safety data from studies conducted by the manufacturers as a condition of their November 2006...
The U.S. Food and Drug Administration announced that Sungwon Inc of Columbia, a Columbia, Md., corporation, and the company’s president, Sang Ja Lee, have signed a consent decree of permanent injunction.
